CA2659645A1 - Pulse inversion sequences for nonlinear imaging - Google Patents
Pulse inversion sequences for nonlinear imaging Download PDFInfo
- Publication number
- CA2659645A1 CA2659645A1 CA002659645A CA2659645A CA2659645A1 CA 2659645 A1 CA2659645 A1 CA 2659645A1 CA 002659645 A CA002659645 A CA 002659645A CA 2659645 A CA2659645 A CA 2659645A CA 2659645 A1 CA2659645 A1 CA 2659645A1
- Authority
- CA
- Canada
- Prior art keywords
- patient
- transducer
- imaging
- contrast agent
- imaging technique
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003384 imaging method Methods 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 claims description 82
- 239000002872 contrast media Substances 0.000 claims description 29
- 238000002604 ultrasonography Methods 0.000 claims description 22
- 230000004044 response Effects 0.000 claims description 18
- 210000001604 vasa vasorum Anatomy 0.000 claims description 7
- 230000009977 dual effect Effects 0.000 claims description 6
- 210000004088 microvessel Anatomy 0.000 claims description 4
- 230000005284 excitation Effects 0.000 claims 14
- 210000001367 artery Anatomy 0.000 claims 2
- 238000012285 ultrasound imaging Methods 0.000 claims 2
- 230000001629 suppression Effects 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 14
- 230000003340 mental effect Effects 0.000 abstract 1
- 238000002608 intravascular ultrasound Methods 0.000 description 17
- 238000001514 detection method Methods 0.000 description 10
- 238000013459 approach Methods 0.000 description 9
- 238000002592 echocardiography Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 6
- 238000004088 simulation Methods 0.000 description 5
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S7/00—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00
- G01S7/52—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00
- G01S7/52017—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00 particularly adapted to short-range imaging
- G01S7/52023—Details of receivers
- G01S7/52036—Details of receivers using analysis of echo signal for target characterisation
- G01S7/52038—Details of receivers using analysis of echo signal for target characterisation involving non-linear properties of the propagation medium or of the reflective target
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
- A61B8/4461—Features of the scanning mechanism, e.g. for moving the transducer within the housing of the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4483—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer
- A61B8/4488—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer the transducer being a phased array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/483—Diagnostic techniques involving the acquisition of a 3D volume of data
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
- G01S15/88—Sonar systems specially adapted for specific applications
- G01S15/89—Sonar systems specially adapted for specific applications for mapping or imaging
- G01S15/8906—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
- G01S15/895—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques characterised by the transmitted frequency spectrum
- G01S15/8956—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques characterised by the transmitted frequency spectrum using frequencies at or above 20 MHz
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
- G01S15/88—Sonar systems specially adapted for specific applications
- G01S15/89—Sonar systems specially adapted for specific applications for mapping or imaging
- G01S15/8906—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
- G01S15/8959—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques using coded signals for correlation purposes
- G01S15/8963—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques using coded signals for correlation purposes using pulse inversion
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S7/00—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00
- G01S7/52—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00
- G01S7/52017—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00 particularly adapted to short-range imaging
- G01S7/52023—Details of receivers
- G01S7/52036—Details of receivers using analysis of echo signal for target characterisation
- G01S7/52038—Details of receivers using analysis of echo signal for target characterisation involving non-linear properties of the propagation medium or of the reflective target
- G01S7/52039—Details of receivers using analysis of echo signal for target characterisation involving non-linear properties of the propagation medium or of the reflective target exploiting the non-linear response of a contrast enhancer, e.g. a contrast agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
- G01S15/88—Sonar systems specially adapted for specific applications
- G01S15/89—Sonar systems specially adapted for specific applications for mapping or imaging
- G01S15/8906—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
- G01S15/8959—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques using coded signals for correlation purposes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G01S15/00—Systems using the reflection or reradiation of acoustic waves, e.g. sonar systems
- G01S15/88—Sonar systems specially adapted for specific applications
- G01S15/89—Sonar systems specially adapted for specific applications for mapping or imaging
- G01S15/8906—Short-range imaging systems; Acoustic microscope systems using pulse-echo techniques
- G01S15/8993—Three dimensional imaging systems
Abstract
Provided herein are Pulse-Inversion (PI) sequences that provide for funda mental frequency suppression in nonlinear imaging applications. In an embodi ment, a weighting scheme is applied to the received echo pulses resulting fr om transmit pulses of alternating polarity to reduce the effect of transduce r motion. In an embodiment, a three-pulse weighting scheme is applied to a P I sequence. In other embodiments, different combinations of the three-pulse weighting scheme are applied to a PI sequence.
Description
PULSE INVERSION SEQUENCES FOR NONLINEAR IMAGING
FIELD OF THE INVENTION
[00011 The present invention relates to pulse inversion sequences for nonlinear tissue imaging and microbubble imaging.
BACKGROUND INFORMATION
[0002] Intravascular ultrasound (IVUS) is an established tool for obtaining ultrasound images within the vascular system. IVUS is a method by which a catheter-based high frequency (e.g., 20 to 50 MHz) transducer is used to create high resolution images of the lumen and vascular wall of larger vessels. It is an established interventional cardiology tool for gaining insight into the size, structure, and composition of atherosclerotic plaque located within coronary arteries.
FIELD OF THE INVENTION
[00011 The present invention relates to pulse inversion sequences for nonlinear tissue imaging and microbubble imaging.
BACKGROUND INFORMATION
[0002] Intravascular ultrasound (IVUS) is an established tool for obtaining ultrasound images within the vascular system. IVUS is a method by which a catheter-based high frequency (e.g., 20 to 50 MHz) transducer is used to create high resolution images of the lumen and vascular wall of larger vessels. It is an established interventional cardiology tool for gaining insight into the size, structure, and composition of atherosclerotic plaque located within coronary arteries.
[0003] Figure 1 shows an exemplary IVUS catheter within a body lumen. The IVUS catheter comprises a transducer at its distal end for obtaining ultrasound images from within the body lumen. The transducer may be comprised of a single element transducer that mechanically scans to create a cross-sectional image, e.g., by rotating the transducer with a drive shaft and having the transducer transmit pulses as it rotates.
Current high frequency imaging systems employ a mechanically scanned single element transducer and single pulse per line image fonnation [0004] Ultrasound images may also be obtained using an array of transducer elements that electronically scans an image. Three-dimensional (3D) imaging may be performed using a two-dimensional (2D) imaging array by mechanically moving the 2D
imaging array to obtain 2D images at different positions and combining the 2D
images to form a 3D image. 3D images may also be obtained using a single transducer element. This may be done by rotating the transducer to obtain 2D images, moving the transducer laterally (e.g., pulling back the transducer) to obtain 2D images at different locations, and combining the 2D images to form a 3D image.
Current high frequency imaging systems employ a mechanically scanned single element transducer and single pulse per line image fonnation [0004] Ultrasound images may also be obtained using an array of transducer elements that electronically scans an image. Three-dimensional (3D) imaging may be performed using a two-dimensional (2D) imaging array by mechanically moving the 2D
imaging array to obtain 2D images at different positions and combining the 2D
images to form a 3D image. 3D images may also be obtained using a single transducer element. This may be done by rotating the transducer to obtain 2D images, moving the transducer laterally (e.g., pulling back the transducer) to obtain 2D images at different locations, and combining the 2D images to form a 3D image.
[0005] Nonlinear tissue imaging techniques have also been developed. In this case, nonlinear propagation of an ultrasound pulse through tissue within the body (increasing with transmit pressure) gives rise to harmonics of the transmit frequency (centered at approximately positive integer multiples of the transmit frequencies). A
nonlinear imaging system generates ultrasound images using the nonlinear echoes arising from nonlinear interactions of the transmitted ultrasound pulses with tissue. The nonlinear echoes may be second harmonic (twice the transmit frequency), or combinations of second and higher order harmonics, referred to as superharmonic imaging, as described by Ayache Bouakaz et al., "Native tissue imaging at superharmonic frequencies," IEEE
Trans Ultrason Ferroelec Freq Control, Vol. 50, No. 5, pp. 496-506, 2003, which is incorporated herein by reference. The formation of nonlinear tissue images can result in a reduction of imaging artifacts and thereby improve image quality. Nonlinear imaging requires isolation of the nonlinear echoes by suppressing the fundamental frequency (i.e., transmit frequency). The fundamental frequency may be suppressed using a pulse inversion (PI) technique, bandpass filtering, or a combination of these approaches. The basic PI technique, as described by David H. Hope Simpson et al., "Pulse inversion doppler: A new method for detecting nonlinear echoes from microbubble contrast agents," IEEE Trans Ultrason Ferroelec Freq Control, Vol.46, No. 2, pp. 372-382, 1999, which is incorporated herein by reference, involves transmitting a pulse and its inverted counterpart along each scan line to cancel out the fundamental signal. A
primary advantage of this approach is that it does not require separate frequency bands for the fundamental and harmonic signals, and thereby permits the use of wider bandwidth transmit signals, which can potentially overlap with the nonlinear signals.
Wide bandwidth transmit signals in turn improve the axial resolution of the imaging system.
nonlinear imaging system generates ultrasound images using the nonlinear echoes arising from nonlinear interactions of the transmitted ultrasound pulses with tissue. The nonlinear echoes may be second harmonic (twice the transmit frequency), or combinations of second and higher order harmonics, referred to as superharmonic imaging, as described by Ayache Bouakaz et al., "Native tissue imaging at superharmonic frequencies," IEEE
Trans Ultrason Ferroelec Freq Control, Vol. 50, No. 5, pp. 496-506, 2003, which is incorporated herein by reference. The formation of nonlinear tissue images can result in a reduction of imaging artifacts and thereby improve image quality. Nonlinear imaging requires isolation of the nonlinear echoes by suppressing the fundamental frequency (i.e., transmit frequency). The fundamental frequency may be suppressed using a pulse inversion (PI) technique, bandpass filtering, or a combination of these approaches. The basic PI technique, as described by David H. Hope Simpson et al., "Pulse inversion doppler: A new method for detecting nonlinear echoes from microbubble contrast agents," IEEE Trans Ultrason Ferroelec Freq Control, Vol.46, No. 2, pp. 372-382, 1999, which is incorporated herein by reference, involves transmitting a pulse and its inverted counterpart along each scan line to cancel out the fundamental signal. A
primary advantage of this approach is that it does not require separate frequency bands for the fundamental and harmonic signals, and thereby permits the use of wider bandwidth transmit signals, which can potentially overlap with the nonlinear signals.
Wide bandwidth transmit signals in turn improve the axial resolution of the imaging system.
[0006) An application of IVUS tissue harmonic imaging is to improve the image quality of atherosclerotic plaque imaging, which may in turn improve diagnosis, treatment planning and therapeutic monitoring. Image artifacts that may be improved with such an approach are catheter sheath artifacts, stent reverberation artifacts, and the presence of calcification within plaques. [0007] Ultrasound contrast imaging employs a contrast agent to enhance the detection and imaging of blood flow or blood vesels within the body. The contrast agent may be comprised of echogenic microbubbles having ultrasound scattering properties that are distinct from those of tissue, thereby enhancing contrast between sites containing the microbubbles and surrounding tissue. Microbubbles are encapsulated gas bubbles of diameters small enough to pass through the capillary beds (typically <10-12 microns) dispersed in an aqueous medium, and may be injected into the blood stream in order to enhance detection of blood vessels (e.g., microvessels) at the imaging location. Typically contrast agents are designed to contain substantial numbers of bubbles of a size that is resonant, or acoustically active at diagnostic ultrasound frequencies (2-10 microns in diameter). These bubbles may have bubbles below 2 microns present, or below 1 micron present. Bubbles can be made to have most bubbles on the order of 1-2 microns in diameter and below. Microbubbles are encapsulated with either a stiff shell or stabilized with a surfactant shell that is compliant (e.g., lipids, albumin). This shell can affect the mechanical properties of bubbles. Microbubbles may also be employed to target (i.e. attach through interaction between molecules within or attached to the microbubble shell and molecular epitopes of interest expressed by tissue within the body) molecules of interest within the body.
This may be achieved by introducing these bubbles into the body and allowing their accumulation at a sight of interest and then imaging them. Microbubbles can be induced to exhibit scattering properties that are different from those of tissue. For example, microbubbles can emit second harmonic signals (at different pressure levels than those required to generate tissue harmonics), superharmonic signals, subharmonic signals (particularly but not exclusively centered near at'/~ the transmit frequency), ultraharmonic signals (particularly but not exclusively at 1.5, 2.5, 3.5 etc of the transmit frequency. Microbubbles can be destroyed, thereby enabling the implementation of indicator dilution techniques. During destruction, broadband acoustic emissions can be made, and interpulse decorrelation can occur. Transient bubble behavior, sensitive to pulse frequency shape and phase, can also be stimulated. Microbubbles are more acoustically active in the vicinity of their resonant frequencies, though advantageous emissions can be induced when transmitting below the resonant frequency (e.g., second harmonic or destruction) or above (e.g., subharmonics). Bubble resonant frequencies are higher for smaller bubbles. In IVUS frequency ranges nonlinear activity of bubbles has been detected in bubbles on the order of 2 microns and below.
[0008] All of the above behaviors, and others can be used either alone or in combination to improve the detection of microbubbles in the presence of tissue for the purposes of improved blood compartment or molecular detection. Examples of microbubbles are disclosed in WO 2006/015876, WO 97/29783, WO 2004/0069284, US 5,271,928, US 5,445,813, US 5413,774, US 5,597,549, US 5,827,504, US
5,711,933, and US 6,333,021, all of which are incorporated herein by reference.
[0009] One application of NUS contrast imaging is in the detection, visualization and quantification of vasa vasorum in or surrounding atherosclerotic plaques.
This would be done for the purposes of diagnosis, treatment planning and therapeutic monitoring. This would be achieved by applying bubble detection procedures following either the local or systemic injection of untargeted contrast agent. The vasa vasorum are microvessels surrounding and penetrating the walls of larger blood vessels. While their precise role is not entirely understood, evidence is mounting that the growth of neovascular vasa vasorum through the process of angiogenesis is a crucial step in the development of atherosclerotic plaques. This realization has led to an emerging interest in the vasa vasorum as a therapeutic target and a growing demand for vasa vasorum imaging techniques. These techniques could also be used in conjunction with tissue structure information provided by IVUS. For example to determine the location of vascularity reltive to plaque structure, potentially useful information. In addition to untargeted agent, targeted contrast agents are also considered for this application. For example, targeting to neovascular endothelial cell markers. Agent could also be targeted to other molecules of interest in atherosclerosis.
[0010] Recently, the feasibility of performing both second harmonic and wide bandwidth subharmonic contrast imaging with an IVUS system operating at high frequencies has been demonstrated by David E. Goertz et al., "Nonlinear Intravascular Ultrasound Contrast Imaging, " Ultrasound in Med & Biol., Vol. 32, No. 4, pp.
502, 2006, which is incorporated herein by reference. These nonlinear contrast imaging approaches provide a promising means for improving vessel lumen boundary detection and IVUS vasa vasorum imaging.
[0011] As discussed above, in nonlinear imaging applications, it is important to achieve effective suppression of the fundamental signal. The basic pulse inversion (PI) technique its widely used for fundamental suppression. However, the effectiveness of the basic PI technique is reduced by transducer motion and the relative motion between the transducer and tissue, which cause the fundamental echoes arising from a transmitted pulse and its inverted counterpart to not cancel out completely.
The reduction in the effectiveness of the PI technique was demonstrated for a mechanically rotating transducer of an IVUS catheter by Martin E. Frijlink et al. "A
simulation Study on Tissue Harmonic Imaging with a Single-element Intravascular Ultrasound Catheter, " J. Acoust. Soc. Am., Vol. 120, No. 3, September 2006, which is incorporated herein by reference.
[0012] Because mechanical scanning requires moving the transducer, nonlinear imaging systems using mechanical scanned transducers suffer greater degradation in fundamental frequency suppression due to motion effects compared with array-based imaging system where the transducers are normally stationary and electrically scanned.
3D imaging using a 2D array-based system also suffers degradation in fundamental frequency suppression due to motion effects because the array has to be mechanically moved to obtain 2D images at different positions to form the 3D image.
[0013] Therefore, there is a need to improve fundamental frequency suppression for nonlinear imaging systems using mechanically scanned transducers.
[0014] Many nonlinear imaging approaches would benefit from improved fundamental frequency suppression. For example, the nonlinear ultrasound contrast imaging approaches discussed above would benefit from improved fundamental frequency suppression. Examples of other imaging approaches that may benefit from improved fundamental frequency suppression include, but are not limited to:
[0015] 1. Broadband signals from bubble disruption. Fundamental suppression is key for discriminating broadband contrast signals from tissue signals.
[0016] 2. `Pulse-inversion fundamental' techniques, which take advantage of energy in the transmit frequency range, which can be present for a number of reasons (e.g., broadening of the fundamental frequency response, asymmetric bubble responses to compressional and rarefactional cycles). A pulse-inversion-based fundamental imaging technique has been described by Che-Chou Shen and Pai-Chi Li, "Pulse-inversion-based fundamental imaging for contrast detection," IEEE Trans Ultrason Ferroelec Freq Control, Vol. 50, No. 9, pp. 1124-1133, 2003, which is incorporated herein by reference. Transducer motion reduces the ability to use Fundamental frequency energy originating from bubble vibrations or reflections.
[0017] 3. Dual frequency approaches, whereby a low frequency signal modulates the high frequency scattering response from bubbles, as described in the patents WO
2005/071437A1 and WO 2006/001697A2, which are incorporated herein by reference.
In this case bubbles are detected in the high frequency transmit bandwidth, using differences from the bubbles during low frequency compression and rarefaction cycles.
A key to the success of this technique is to achieve the effective suppression of the tissue signal at high frequencies, through for example pulse inversion (or subtraction in post-processing) techniques, which can be corrupted by relative tissue and transducer motion.
[0018] 4. `Repetition rate imaging', where larger bubbles are stimulated to oscillate by sending high frequency ultrasound pulses at a pulse repetition frequency (PRF) at or near the bubble resonant frequencies, as described by Hendrik J.
Vos et al., "Repetition rate imaging of bubbles", abstract of the Eleventh European Symposium on Ultrasound Contrast Imaging, Rotterdam, the Netherlands, January 26-27, 2006, which is incorporated herein by reference. Differences between oscillating bubbles and tissue may then be detected with appropriate pulse inversion sequences, where fundamental frequency suppression may be critical in the success of this technique.
[0019] 5. `Bubble memory' techniques, which use the subtraction of pulses of different lengths to isolate tissue and bubble signals, based on the assumption that the acoustic response of tissue is `memoryless', whereas bubbles have `memory', as described in the patent WO 2006/021400A1, which is incorporated herein by reference.
Optimized subtraction, reducing the effect of a moving transducer relative to the tissue and contrast, of pulses is key to the success of this technique.
[0020] 6. Combinations of above mentioned techniques.
[0021] These imaging approaches suffer even more from poor fundamental frequency suppression.
SUMMARY
[0022] Provided herein are Pulse-hlversion (PI) sequences that provide for fundamental frequency suppression in nonlinear imaging applications. Examples of nonlinear imaging applications include second harmonic, subharmonic, and ultraharmonic contrast imaging. In an embodiment, a weighting scheme is applied to the received echo pulses resulting from transmit pulses of alternating polarity to reduce the effect of transducer motion. In an embodiment, a three-pulse weighting scheme is applied to a PI sequence. In other embodiments, different combinations of the three-pulse weighting scheme are applied to a PI sequence.
BRIEF DESCRIPTION OF THE FIGURES
[0023] Figure 1 sliows an exemplary IVUS catheter with a transducer at its distal end.
[0024] Figure 2 is a graph showing the effects of different PI-sequences as compared to no PI and basic PI for an inter-pulse angle of 0.15 .
[0025] Figure 3 is a graph showing the effects of different PI-sequences as compared to no PI and basic PI for an inter-pulse angle of 0.30 .
DETAILED DESCRIPTION
[0026] Provided herein are PI-sequences that achieve significant improvements on the fundamental suppression (of both tissue and contrast) for nonlinear image acquisitions, e.g., with a mechanically scanned transducer. These nonlinear acquisitions may include subharmonic, second harmonic, fundamental PI and dual-frequency-exposure acquisitions.
[0027] The PI-technique according to the invention applies weighting schemes for processing the received echoes from transmit pulses of alternating polarity to reduce the effect of transducer motion based on the assumption that optimal cancellation of one pulse is achieved by adding the average of two adjacent pulses of opposite polarity.
[0028] In an embodiment, the PI-technique applies a weighting scheme that results in a basic 3-pulse sequence of [P1 - + 2=P2+ + P3-], where [P+] is the response from a positive polarity pulse and [P- ] the response of a negative (opposite) polarity pulse.
Linear combinations of this basic 3-pulse sequence can be described by the following first generalization:
n [0029] 1. P+/ + 2Pt ++ + P,+' for n= l, 2, 3, 4, 5, 6, 7, ...
r=, [0030] where t and t+l indicate neighboring pulse responses. This results in multi-pulse sequences with the following weight-factors:
[0031] 1-2-1 [0032] 1-3-3-1 [0033] 1-3-4-3-1 [0034] 1-3-4-4-3-1 [0035] 1-3-4-4-4-3-1 [0036] 1-3-4-...-4-3-1 [0037] Linear combinations of the basic 3-pulse sequence can also be described by the following second generalization:
[0038] 2. Y P+'- + 2- P, ;+ + P,+; for n= 1, 3, 5, 7, 9, 11,...
r=~
[0039] where the index of summation t is increment by two instead of one, as in the first generalization. This results in multi-pulse sequences with the following weightfactors:
[0040] 1-2-1 [00411 1-2-2-2-1 [0042] 1-2-2-2-2-2-1 [0043] 1-2-2-...-2-2-1 [0044] As with tissue second harmonic imaging, the use of the described Pulse-Inversion Sequences will also be beneficial for second harmonic, subharmonic and ultraharmonic microbubble imaging. In these circumstances the center frequency of the nonlinear frequency bands are separate from the transmit separate frequency;
however, for wider bandwidth signals (beneficial for improved axial resolution) there may be considerable overlap in the frequency content of these bands. A more effective cancellation of the fundamental frequency tissue signals will again reduce the requirement of real-time bandpass filtering and enable the inclusion of more contrast signal bandwidth. The latter point is particularly significant since the harmonic and subharmonic signals are broadened by the bubble response, even in the absence of microbubble disruption.
[00451 The use of the Pulse-Inversion Sequences in the context of contrast imaging may be particularly useful when employing bubble detection techniques that do not rely upon the use of separate frequency bands for the separation of contrast and tissue signals. In this case residual tissue signals from tissue motion will severely degrade the contrast to tissue ratios. Techniques that would also benefit from the inventive Pulse-Inversion Sequences to enhance fundamental suppression include, but are not limited to: broadband bubble destruction imaging, fundamental frequency imaging, dual frequency imaging, repetition rate imaging, and bubble memory imaging techniques, techniques which have been described in more detail in the background section.
[0046] The Pulse-filversion Sequences may be used in these contrast detection techniques by applying the proposed weighting schemes for processing the received echoes from transmit pulses of alternating polarity. For optimal use, it may be beneficial for some contrast imaging techniques to replace the transmit sequence (e.g., changing the order of the transmit pulses, adding transmit pulses, etc.).
[0047] Initial simulations suggest that the beam shape can have its effect on the pulse weighting if more than 3 receive pulses are combined. The beam shape might be used to weight the basic weighting scheme [-1 2-1 ], which subsequently may be dependent on the depth.
[0048] A specific example of a high-frequency application with a mechanically-scanned transducer is harmonic IVUS with a continuously-rotating single-element. For this example, initial simulations were performed.
This may be achieved by introducing these bubbles into the body and allowing their accumulation at a sight of interest and then imaging them. Microbubbles can be induced to exhibit scattering properties that are different from those of tissue. For example, microbubbles can emit second harmonic signals (at different pressure levels than those required to generate tissue harmonics), superharmonic signals, subharmonic signals (particularly but not exclusively centered near at'/~ the transmit frequency), ultraharmonic signals (particularly but not exclusively at 1.5, 2.5, 3.5 etc of the transmit frequency. Microbubbles can be destroyed, thereby enabling the implementation of indicator dilution techniques. During destruction, broadband acoustic emissions can be made, and interpulse decorrelation can occur. Transient bubble behavior, sensitive to pulse frequency shape and phase, can also be stimulated. Microbubbles are more acoustically active in the vicinity of their resonant frequencies, though advantageous emissions can be induced when transmitting below the resonant frequency (e.g., second harmonic or destruction) or above (e.g., subharmonics). Bubble resonant frequencies are higher for smaller bubbles. In IVUS frequency ranges nonlinear activity of bubbles has been detected in bubbles on the order of 2 microns and below.
[0008] All of the above behaviors, and others can be used either alone or in combination to improve the detection of microbubbles in the presence of tissue for the purposes of improved blood compartment or molecular detection. Examples of microbubbles are disclosed in WO 2006/015876, WO 97/29783, WO 2004/0069284, US 5,271,928, US 5,445,813, US 5413,774, US 5,597,549, US 5,827,504, US
5,711,933, and US 6,333,021, all of which are incorporated herein by reference.
[0009] One application of NUS contrast imaging is in the detection, visualization and quantification of vasa vasorum in or surrounding atherosclerotic plaques.
This would be done for the purposes of diagnosis, treatment planning and therapeutic monitoring. This would be achieved by applying bubble detection procedures following either the local or systemic injection of untargeted contrast agent. The vasa vasorum are microvessels surrounding and penetrating the walls of larger blood vessels. While their precise role is not entirely understood, evidence is mounting that the growth of neovascular vasa vasorum through the process of angiogenesis is a crucial step in the development of atherosclerotic plaques. This realization has led to an emerging interest in the vasa vasorum as a therapeutic target and a growing demand for vasa vasorum imaging techniques. These techniques could also be used in conjunction with tissue structure information provided by IVUS. For example to determine the location of vascularity reltive to plaque structure, potentially useful information. In addition to untargeted agent, targeted contrast agents are also considered for this application. For example, targeting to neovascular endothelial cell markers. Agent could also be targeted to other molecules of interest in atherosclerosis.
[0010] Recently, the feasibility of performing both second harmonic and wide bandwidth subharmonic contrast imaging with an IVUS system operating at high frequencies has been demonstrated by David E. Goertz et al., "Nonlinear Intravascular Ultrasound Contrast Imaging, " Ultrasound in Med & Biol., Vol. 32, No. 4, pp.
502, 2006, which is incorporated herein by reference. These nonlinear contrast imaging approaches provide a promising means for improving vessel lumen boundary detection and IVUS vasa vasorum imaging.
[0011] As discussed above, in nonlinear imaging applications, it is important to achieve effective suppression of the fundamental signal. The basic pulse inversion (PI) technique its widely used for fundamental suppression. However, the effectiveness of the basic PI technique is reduced by transducer motion and the relative motion between the transducer and tissue, which cause the fundamental echoes arising from a transmitted pulse and its inverted counterpart to not cancel out completely.
The reduction in the effectiveness of the PI technique was demonstrated for a mechanically rotating transducer of an IVUS catheter by Martin E. Frijlink et al. "A
simulation Study on Tissue Harmonic Imaging with a Single-element Intravascular Ultrasound Catheter, " J. Acoust. Soc. Am., Vol. 120, No. 3, September 2006, which is incorporated herein by reference.
[0012] Because mechanical scanning requires moving the transducer, nonlinear imaging systems using mechanical scanned transducers suffer greater degradation in fundamental frequency suppression due to motion effects compared with array-based imaging system where the transducers are normally stationary and electrically scanned.
3D imaging using a 2D array-based system also suffers degradation in fundamental frequency suppression due to motion effects because the array has to be mechanically moved to obtain 2D images at different positions to form the 3D image.
[0013] Therefore, there is a need to improve fundamental frequency suppression for nonlinear imaging systems using mechanically scanned transducers.
[0014] Many nonlinear imaging approaches would benefit from improved fundamental frequency suppression. For example, the nonlinear ultrasound contrast imaging approaches discussed above would benefit from improved fundamental frequency suppression. Examples of other imaging approaches that may benefit from improved fundamental frequency suppression include, but are not limited to:
[0015] 1. Broadband signals from bubble disruption. Fundamental suppression is key for discriminating broadband contrast signals from tissue signals.
[0016] 2. `Pulse-inversion fundamental' techniques, which take advantage of energy in the transmit frequency range, which can be present for a number of reasons (e.g., broadening of the fundamental frequency response, asymmetric bubble responses to compressional and rarefactional cycles). A pulse-inversion-based fundamental imaging technique has been described by Che-Chou Shen and Pai-Chi Li, "Pulse-inversion-based fundamental imaging for contrast detection," IEEE Trans Ultrason Ferroelec Freq Control, Vol. 50, No. 9, pp. 1124-1133, 2003, which is incorporated herein by reference. Transducer motion reduces the ability to use Fundamental frequency energy originating from bubble vibrations or reflections.
[0017] 3. Dual frequency approaches, whereby a low frequency signal modulates the high frequency scattering response from bubbles, as described in the patents WO
2005/071437A1 and WO 2006/001697A2, which are incorporated herein by reference.
In this case bubbles are detected in the high frequency transmit bandwidth, using differences from the bubbles during low frequency compression and rarefaction cycles.
A key to the success of this technique is to achieve the effective suppression of the tissue signal at high frequencies, through for example pulse inversion (or subtraction in post-processing) techniques, which can be corrupted by relative tissue and transducer motion.
[0018] 4. `Repetition rate imaging', where larger bubbles are stimulated to oscillate by sending high frequency ultrasound pulses at a pulse repetition frequency (PRF) at or near the bubble resonant frequencies, as described by Hendrik J.
Vos et al., "Repetition rate imaging of bubbles", abstract of the Eleventh European Symposium on Ultrasound Contrast Imaging, Rotterdam, the Netherlands, January 26-27, 2006, which is incorporated herein by reference. Differences between oscillating bubbles and tissue may then be detected with appropriate pulse inversion sequences, where fundamental frequency suppression may be critical in the success of this technique.
[0019] 5. `Bubble memory' techniques, which use the subtraction of pulses of different lengths to isolate tissue and bubble signals, based on the assumption that the acoustic response of tissue is `memoryless', whereas bubbles have `memory', as described in the patent WO 2006/021400A1, which is incorporated herein by reference.
Optimized subtraction, reducing the effect of a moving transducer relative to the tissue and contrast, of pulses is key to the success of this technique.
[0020] 6. Combinations of above mentioned techniques.
[0021] These imaging approaches suffer even more from poor fundamental frequency suppression.
SUMMARY
[0022] Provided herein are Pulse-hlversion (PI) sequences that provide for fundamental frequency suppression in nonlinear imaging applications. Examples of nonlinear imaging applications include second harmonic, subharmonic, and ultraharmonic contrast imaging. In an embodiment, a weighting scheme is applied to the received echo pulses resulting from transmit pulses of alternating polarity to reduce the effect of transducer motion. In an embodiment, a three-pulse weighting scheme is applied to a PI sequence. In other embodiments, different combinations of the three-pulse weighting scheme are applied to a PI sequence.
BRIEF DESCRIPTION OF THE FIGURES
[0023] Figure 1 sliows an exemplary IVUS catheter with a transducer at its distal end.
[0024] Figure 2 is a graph showing the effects of different PI-sequences as compared to no PI and basic PI for an inter-pulse angle of 0.15 .
[0025] Figure 3 is a graph showing the effects of different PI-sequences as compared to no PI and basic PI for an inter-pulse angle of 0.30 .
DETAILED DESCRIPTION
[0026] Provided herein are PI-sequences that achieve significant improvements on the fundamental suppression (of both tissue and contrast) for nonlinear image acquisitions, e.g., with a mechanically scanned transducer. These nonlinear acquisitions may include subharmonic, second harmonic, fundamental PI and dual-frequency-exposure acquisitions.
[0027] The PI-technique according to the invention applies weighting schemes for processing the received echoes from transmit pulses of alternating polarity to reduce the effect of transducer motion based on the assumption that optimal cancellation of one pulse is achieved by adding the average of two adjacent pulses of opposite polarity.
[0028] In an embodiment, the PI-technique applies a weighting scheme that results in a basic 3-pulse sequence of [P1 - + 2=P2+ + P3-], where [P+] is the response from a positive polarity pulse and [P- ] the response of a negative (opposite) polarity pulse.
Linear combinations of this basic 3-pulse sequence can be described by the following first generalization:
n [0029] 1. P+/ + 2Pt ++ + P,+' for n= l, 2, 3, 4, 5, 6, 7, ...
r=, [0030] where t and t+l indicate neighboring pulse responses. This results in multi-pulse sequences with the following weight-factors:
[0031] 1-2-1 [0032] 1-3-3-1 [0033] 1-3-4-3-1 [0034] 1-3-4-4-3-1 [0035] 1-3-4-4-4-3-1 [0036] 1-3-4-...-4-3-1 [0037] Linear combinations of the basic 3-pulse sequence can also be described by the following second generalization:
[0038] 2. Y P+'- + 2- P, ;+ + P,+; for n= 1, 3, 5, 7, 9, 11,...
r=~
[0039] where the index of summation t is increment by two instead of one, as in the first generalization. This results in multi-pulse sequences with the following weightfactors:
[0040] 1-2-1 [00411 1-2-2-2-1 [0042] 1-2-2-2-2-2-1 [0043] 1-2-2-...-2-2-1 [0044] As with tissue second harmonic imaging, the use of the described Pulse-Inversion Sequences will also be beneficial for second harmonic, subharmonic and ultraharmonic microbubble imaging. In these circumstances the center frequency of the nonlinear frequency bands are separate from the transmit separate frequency;
however, for wider bandwidth signals (beneficial for improved axial resolution) there may be considerable overlap in the frequency content of these bands. A more effective cancellation of the fundamental frequency tissue signals will again reduce the requirement of real-time bandpass filtering and enable the inclusion of more contrast signal bandwidth. The latter point is particularly significant since the harmonic and subharmonic signals are broadened by the bubble response, even in the absence of microbubble disruption.
[00451 The use of the Pulse-Inversion Sequences in the context of contrast imaging may be particularly useful when employing bubble detection techniques that do not rely upon the use of separate frequency bands for the separation of contrast and tissue signals. In this case residual tissue signals from tissue motion will severely degrade the contrast to tissue ratios. Techniques that would also benefit from the inventive Pulse-Inversion Sequences to enhance fundamental suppression include, but are not limited to: broadband bubble destruction imaging, fundamental frequency imaging, dual frequency imaging, repetition rate imaging, and bubble memory imaging techniques, techniques which have been described in more detail in the background section.
[0046] The Pulse-filversion Sequences may be used in these contrast detection techniques by applying the proposed weighting schemes for processing the received echoes from transmit pulses of alternating polarity. For optimal use, it may be beneficial for some contrast imaging techniques to replace the transmit sequence (e.g., changing the order of the transmit pulses, adding transmit pulses, etc.).
[0047] Initial simulations suggest that the beam shape can have its effect on the pulse weighting if more than 3 receive pulses are combined. The beam shape might be used to weight the basic weighting scheme [-1 2-1 ], which subsequently may be dependent on the depth.
[0048] A specific example of a high-frequency application with a mechanically-scanned transducer is harmonic IVUS with a continuously-rotating single-element. For this example, initial simulations were performed.
[0049] Simulations [0050] A simulation tool was developed to calculate nonlinear high-frequency beams in tissue-mimicking media and to investigate the influence of transducer rotation on the efficiency of the weighted.PI-signal processing. In this example, 20 MHz Gaussian pulses (2 MPa, 50% bandwidth) were propagated through a scattering and attenuating (1.0 dBXcm-1 xMHz-1) medium, resulting in the generation of second harmonic signal at 40 MHz. Fundamental suppression was investigated for a range of inter-pulse angles (0.15 -1.5 ) for different PI-sequences. The inter-pulse angle of 0.15 corresponds to the angle as used in initial harmonic IVUS experiments as performed with a prototype system using a line-density of 2400 lines per rotation. The inter-pulse angle of 1.5 corresponds to an angle with a line density of 2561ines per rotation.
[0051] Figure 1 shows the effects of different PI-sequences as compared to no Pulse-Inversion and to basic PI using [PI " + Pz+], for an inter-pulse angle of 0.15 .
[0052] The average fundamental reduction between 18 and 22 MHz as compared to a single RF-trace is given in the table below:
Sequence Average reduction between 18 - 22 Extra reduction vs. basic MHz PI
[1 1] (basic 28.2 dB 0 dB
PI) [1 2 1] 34.8 dB 6.6 dB
[1222221] 38.8dB 10.6dB
[1344431] 38.5dB 10.3dB
[0053] The same has been simulated for an inter-pulse angle of 0.30 . Figure 2 shows the effects of different PI-sequences as compared to no Pulse-Inversion and to basic PI using [Pl- + Pz+], for an inter-pulse angle of 0.30 .
[0054] The average fundamental reduction between 18 and 22 MHz as compared to a single RF-trace is given in the table below:
Sequence Average reduction between 18 - 22 Extra reduction vs basic MHz PI
[1 1] (basic 23.0 dB 0 dB
PI) [1 2 1] 32.3 dB 9.3 dB
[1222221] 35.9dB 12.9dB
[0051] Figure 1 shows the effects of different PI-sequences as compared to no Pulse-Inversion and to basic PI using [PI " + Pz+], for an inter-pulse angle of 0.15 .
[0052] The average fundamental reduction between 18 and 22 MHz as compared to a single RF-trace is given in the table below:
Sequence Average reduction between 18 - 22 Extra reduction vs. basic MHz PI
[1 1] (basic 28.2 dB 0 dB
PI) [1 2 1] 34.8 dB 6.6 dB
[1222221] 38.8dB 10.6dB
[1344431] 38.5dB 10.3dB
[0053] The same has been simulated for an inter-pulse angle of 0.30 . Figure 2 shows the effects of different PI-sequences as compared to no Pulse-Inversion and to basic PI using [Pl- + Pz+], for an inter-pulse angle of 0.30 .
[0054] The average fundamental reduction between 18 and 22 MHz as compared to a single RF-trace is given in the table below:
Sequence Average reduction between 18 - 22 Extra reduction vs basic MHz PI
[1 1] (basic 23.0 dB 0 dB
PI) [1 2 1] 32.3 dB 9.3 dB
[1222221] 35.9dB 12.9dB
[1344431] 36.5dB 13.5dB
[0055] The graphs in Figures 1 and 2 only show the result of three of the proposed PI-sequences. Also, different interpulse angles will result in different effects of the proposed PI-sequences. [0056] A 3-pulse PI-sequence [1 2 1] was also applied on RF-data from IVUS THI
acquisitions (inter-pulse angle 0.15 ) in rabbit aortas in vivo. The 3-pulse sequence improved the fundamental suppression by > 6 dB.
[0057] Therefore, the effective application of weighted PI-sequences to reduce the effects of transducer rotation on fundamental frequency suppression has been shown.
The weighted PI-sequences will help reduce relative tissue/transducer motion effects, leading to improved image quality in nonlinear tissue and contrast imaging.
The weighted PI-sequences are ideally suited for fast real-time implementation, thereby reducing the requirements for relatively time-consuming digital bandpass filtering.
[0058] While embodiments of the present invention has been shown and described, various modifications may be made without departing from the scope of the present invention, and all such modifications and equivalents are intended to be covered.
[0059] References [0060] [1] Bouakaz A, de Jong N, Native tissue imaging at superharmonic frequencies, IEEE Trans Ultrason Ferroelec Freq Contro12003, 50 (5): 496-506.
[0061] [2] Hope Simpson DH, Chin CT, Burns PN, Pulse inversion doppler: A new method for detecting nonlinear echoes from microbubble contrast agents, IEEE
Trans Ultrason Ferroelec Freq Control 1999, 46 (2): 372-382.
[0062] [3] Goertz DE, Frijlink ME, de Jong N, van der Steen AFW, Nonlinear intravascular ultrasound contrast imaging, Ultrasound Med Bio12006, 32(4): 491-502.
[0055] The graphs in Figures 1 and 2 only show the result of three of the proposed PI-sequences. Also, different interpulse angles will result in different effects of the proposed PI-sequences. [0056] A 3-pulse PI-sequence [1 2 1] was also applied on RF-data from IVUS THI
acquisitions (inter-pulse angle 0.15 ) in rabbit aortas in vivo. The 3-pulse sequence improved the fundamental suppression by > 6 dB.
[0057] Therefore, the effective application of weighted PI-sequences to reduce the effects of transducer rotation on fundamental frequency suppression has been shown.
The weighted PI-sequences will help reduce relative tissue/transducer motion effects, leading to improved image quality in nonlinear tissue and contrast imaging.
The weighted PI-sequences are ideally suited for fast real-time implementation, thereby reducing the requirements for relatively time-consuming digital bandpass filtering.
[0058] While embodiments of the present invention has been shown and described, various modifications may be made without departing from the scope of the present invention, and all such modifications and equivalents are intended to be covered.
[0059] References [0060] [1] Bouakaz A, de Jong N, Native tissue imaging at superharmonic frequencies, IEEE Trans Ultrason Ferroelec Freq Contro12003, 50 (5): 496-506.
[0061] [2] Hope Simpson DH, Chin CT, Burns PN, Pulse inversion doppler: A new method for detecting nonlinear echoes from microbubble contrast agents, IEEE
Trans Ultrason Ferroelec Freq Control 1999, 46 (2): 372-382.
[0062] [3] Goertz DE, Frijlink ME, de Jong N, van der Steen AFW, Nonlinear intravascular ultrasound contrast imaging, Ultrasound Med Bio12006, 32(4): 491-502.
Claims (55)
1. A method for ultrasound imaging of a patient's body, comprising:
transmitting ultrasound excitation pulses of alternating polarity into the patient's body;
receiving ultrasound echo signals in response to the excitation signals; and applying a weighting scheme to the received ultrasound echo signals, wherein the weighting scheme is given by where t is an index of summation incremented by 1, P+/- and P-/+ are echo signals in response to excitation pulses of opposite polarities, n is an upper bound of summation, and a, b, and c are weighting coefficients.
transmitting ultrasound excitation pulses of alternating polarity into the patient's body;
receiving ultrasound echo signals in response to the excitation signals; and applying a weighting scheme to the received ultrasound echo signals, wherein the weighting scheme is given by where t is an index of summation incremented by 1, P+/- and P-/+ are echo signals in response to excitation pulses of opposite polarities, n is an upper bound of summation, and a, b, and c are weighting coefficients.
2. The method of claim 1, wherein n is 2 or larger.
3. The method of claim 1, wherein n is 3 or larger.
4. The method of claim 1, wherein a, b, and c equal 1, 2, and 1, respectively.
5. The method of claim 1, wherein the received echo signals include harmonic responses.
6. The method of claim 1, wherein the received echo signals include subharmonic responses.
7. The method of claim 1, wherein the received echo signals include ultraharmonic responses.
8. The method of claim 1, further comprising:
introducing a catheter-based ultrasound transducer into the patient's body at a site of interest; and mechanically scanning the transducer to image the site of interest.
introducing a catheter-based ultrasound transducer into the patient's body at a site of interest; and mechanically scanning the transducer to image the site of interest.
9. The method of claim 8, wherein the site of interest is an artery.
10. The method of claim 8, further comprising introducing a contrast agent into the patient's body, wherein the excitation pulses interact differently with tissue and the contrast agent.
11. The method of claim 10, wherein the contrast agent is injected is injected into the patient's body in the vicinity of the transducer.
12. The method of claim 10, wherein the contrast agent is located in the microvessels vasarum.
13. The method of claim 10, wherein the excitation pulses are transmitted at a center frequency of 15 MHz or greater.
14. The method of claim 10, wherein the excitation pulses are transmitted at a center frequency of 20 MHz or greater.
15. The method of claim 8, wherein mechanically scanning the transducer comprises rotating the transducer.
16. The method of claim 1, wherein the transducer comprises a transducer array, the method further comprising:
mechanically moving the transducer array;
obtaining multiple two-dimensional images with the transducer array as the transducer array is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
mechanically moving the transducer array;
obtaining multiple two-dimensional images with the transducer array as the transducer array is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
17. The method of claim 1, wherein the transducer comprises a single transducer element, the method further comprising:
mechanically moving the single transducer element;
obtaining multiple two-dimensional images with the single transducer element as the single transducer element is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
mechanically moving the single transducer element;
obtaining multiple two-dimensional images with the single transducer element as the single transducer element is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
18. The method of claim 1, further comprising introducing a contrast agent into the patient's body, wherein the excitation pulses interact differently with tissue and the contrast agent.
19. The method of claim 18, wherein the contrast agent comprises microbubbles.
20. The method of claim 18, wherein the contrast agent is adapted to selectively locate at sites, or in regions, of specific character.
21. The method of claim 18, wherein the contrast agent is untargeted.
22. The method of claim 18, wherein the contrast agent is injected into the patient's body in the vicinity of the transducer.
23. The method of claim 18, wherein the contrast agent is injected into the patient's body at a location away from the transducer.
24. The method of claim 19, further comprising imaging within the patient's body using a bubble disruption imaging technique.
25. The method of claim 19, further comprising imaging within the patient's body using a dual frequency imaging technique.
26. The method of claim 19, further comprising imaging within the patient's body using a repetition rate imaging technique.
27. The method of claim 19, further comprising imaging within the patient's body using a bubble memory imaging technique.
28. The method of claim 19, further comprising imaging within the patient's body using a bubble disruption imaging technique, a dual frequency imaging technique, a repetition rate imaging technique, a bubble memory imaging technique, or a combination thereof.
29. A method for ultrasound imaging within a patient's body, comprising:
transmitting ultrasound excitation pulses of alternating polarity into the patient's body;
receiving ultrasound echo signals in response to the excitation signals; and applying a weighting scheme to the received ultrasound echo signals, wherein the weighting scheme is given by where t is an index of summation incremented by 2, P+/- and P-/+ are echo signals in response to excitation pulses of opposite polarities, n is an upper bound of summation, and a, b, and c are weighting coefficients.
transmitting ultrasound excitation pulses of alternating polarity into the patient's body;
receiving ultrasound echo signals in response to the excitation signals; and applying a weighting scheme to the received ultrasound echo signals, wherein the weighting scheme is given by where t is an index of summation incremented by 2, P+/- and P-/+ are echo signals in response to excitation pulses of opposite polarities, n is an upper bound of summation, and a, b, and c are weighting coefficients.
30. The method of claim 29, wherein n is 2 or larger.
31. The method of claim 29, wherein a, b, and c equal 1, 2, and 1, respectively.
32. The method of claim 29, wherein the received echo signals include harmonic responses.
33. The method of claim 29, wherein the received echo signals include subharmonic responses.
34. The method of claim 29, wherein the received echo signals include ultraharmonic responses.
35. The method of claim 29, further comprising:
introducing a catheter-based ultrasound transducer into the patient's body at a site of interest; and mechanically scanning the transducer to image the site of interest.
introducing a catheter-based ultrasound transducer into the patient's body at a site of interest; and mechanically scanning the transducer to image the site of interest.
36. The method of claim 35, wherein the site of interest is an artery.
37. The method of claim 35, further comprising introducing a contrast agent into the patient's body, wherein the excitation pulses interact differently with tissue and the contrast agent.
38. The method of claim 37, wherein the contrast agent is injected is injected into the patient's body in the vicinity of the transducer.
39. The method of claim 37, wherein the contrast agent is located in the microvessels vasa vasorum.
40. The method of claim 37, wherein the excitation pulses are transmitted at a center frequency of 15 MHz or greater.
41. The method of claim 37, wherein the excitation pulses are transmitted at a center frequency of 20 MHz or greater.
42. The method of claim 35, wherein mechanically scanning the transducer comprises rotating the transducer.
43. The method of claim 29, wherein the transducer comprises a transducer array, the method further comprising:
mechanically moving the transducer array;
obtaining multiple two-dimensional images with the transducer array as the transducer array is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
mechanically moving the transducer array;
obtaining multiple two-dimensional images with the transducer array as the transducer array is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
44. The method of claim 29, wherein the transducer comprises a single transducer element, the method further comprising:
mechanically moving the single transducer element;
obtaining multiple two-dimensional images with the single transducer element as the single transducer element is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
mechanically moving the single transducer element;
obtaining multiple two-dimensional images with the single transducer element as the single transducer element is moved; and combining the multiple two-dimensional images to form a three-dimensional image.
45. The method of claim 29, further comprising introducing a contrast agent into the patient's body, wherein the excitation pulses interact differently with tissue and the contrast agent.
46. The method of claim 45, wherein the contrast agent comprises microbubbles.
47. The method of claim 45, wherein the contrast agent is adapted to selectively locate at sites, or in regions, of specific character.
48. The method of claim 45, wherein the contrast agent is untargeted.
49. The method of claim 45, wherein the contrast agent is injected into the patient's body in the vicinity of the transducer.
50. The method of claim 45, wherein the contrast agent is injected into the patient's body at a location away from the transducer.
51. The method of claim 46, further comprising imaging within the patient's body using a bubble disruption imaging technique.
52. The method of claim 46, further comprising imaging within the patient's body using a dual frequency imaging technique.
53. The method of claim 46, further comprising imaging within the patient's body using a repetition rate imaging technique.
54. The method of claim 46, further comprising imaging within the patient's body using a bubble memory imaging technique.
55. The method of claim 46, further comprising imaging within the patient's body using a bubble disruption imaging technique, a dual frequency imaging technique, a repetition rate imaging technique, a bubble memory imaging technique, or a combination thereof.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82110606P | 2006-08-01 | 2006-08-01 | |
US60/821,106 | 2006-08-01 | ||
US82486206P | 2006-09-07 | 2006-09-07 | |
US60/824,862 | 2006-09-07 | ||
PCT/US2007/074996 WO2008016992A1 (en) | 2006-08-01 | 2007-08-01 | Pulse inversion sequences for nonlinear imaging |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2659645A1 true CA2659645A1 (en) | 2008-02-07 |
CA2659645C CA2659645C (en) | 2015-06-30 |
Family
ID=38695506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2659645A Active CA2659645C (en) | 2006-08-01 | 2007-08-01 | Pulse inversion sequences for nonlinear imaging |
Country Status (5)
Country | Link |
---|---|
US (1) | US7967753B2 (en) |
EP (1) | EP2076179B1 (en) |
JP (1) | JP5154554B2 (en) |
CA (1) | CA2659645C (en) |
WO (1) | WO2008016992A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5322522B2 (en) * | 2008-07-11 | 2013-10-23 | 株式会社東芝 | Ultrasonic diagnostic equipment |
JP2010063493A (en) * | 2008-09-08 | 2010-03-25 | Aloka Co Ltd | Ultrasonic diagnostic apparatus |
KR101812492B1 (en) * | 2009-10-12 | 2017-12-27 | 실리콘 밸리 메디컬 인스트루먼츠, 인코포레이티드 | Intravascular Ultrasound System for Co-Registered Imaging |
US9216008B2 (en) | 2012-01-30 | 2015-12-22 | Technion Research & Development Foundation Limited | Quantitative assessment of neovascularization |
US9693754B2 (en) | 2013-05-15 | 2017-07-04 | Acist Medical Systems, Inc. | Imaging processing systems and methods |
JP6353038B2 (en) | 2013-10-07 | 2018-07-04 | アシスト・メディカル・システムズ,インコーポレイテッド | Signal processing for intravascular imaging |
EP3097432B1 (en) | 2014-01-23 | 2022-07-06 | Supersonic Imagine | Method for determining a physical characteristic on a punctual location inside a medium, a method for determining an image of a medium and apparatus implementing saids methods |
US10909661B2 (en) | 2015-10-08 | 2021-02-02 | Acist Medical Systems, Inc. | Systems and methods to reduce near-field artifacts |
US10653393B2 (en) | 2015-10-08 | 2020-05-19 | Acist Medical Systems, Inc. | Intravascular ultrasound imaging with frequency selective imaging methods and systems |
US11369337B2 (en) | 2015-12-11 | 2022-06-28 | Acist Medical Systems, Inc. | Detection of disturbed blood flow |
JP7104632B2 (en) | 2015-12-31 | 2022-07-21 | アシスト・メディカル・システムズ,インコーポレイテッド | Semi-automated image segmentation system and method |
CN109478332B (en) | 2016-05-16 | 2023-04-25 | 阿西斯特医药系统公司 | Motion-based image segmentation system and method |
US11024034B2 (en) | 2019-07-02 | 2021-06-01 | Acist Medical Systems, Inc. | Image segmentation confidence determination |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US518177A (en) * | 1894-04-10 | cirse | ||
US586575A (en) * | 1897-07-20 | Lightning-arrester for switchboards | ||
US628031A (en) * | 1898-06-02 | 1899-07-04 | William T Parker | Adjustable lid-holder for boxes. |
US657910A (en) * | 1900-02-03 | 1900-09-18 | Willard F Barber | Metallic cement for electric-conductor joints. |
US666824A (en) * | 1900-06-09 | 1901-01-29 | Lyman T Smith | Valve for pneumatic tires. |
US3778756A (en) * | 1972-09-01 | 1973-12-11 | Gen Electric | Method and apparatus for visual imaging of ultrasonic echo signals utilizing a single transmitter |
US4217909A (en) | 1978-08-23 | 1980-08-19 | General Electric Company | Directional detection of blood velocities in an ultrasound system |
US5410516A (en) * | 1988-09-01 | 1995-04-25 | Schering Aktiengesellschaft | Ultrasonic processes and circuits for performing them |
DE3829999A1 (en) | 1988-09-01 | 1990-03-15 | Schering Ag | ULTRASONIC METHOD AND CIRCUITS THEREOF |
JP2735266B2 (en) | 1989-02-15 | 1998-04-02 | 株式会社日立製作所 | Pulse echo type ultrasonic device |
IN172208B (en) | 1990-04-02 | 1993-05-01 | Sint Sa | |
US5445813A (en) * | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
AU636481B2 (en) | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
US5186177A (en) | 1991-12-05 | 1993-02-16 | General Electric Company | Method and apparatus for applying synthetic aperture focusing techniques to a catheter based system for high frequency ultrasound imaging of small vessels |
IL104084A (en) | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them |
US5269307A (en) * | 1992-01-31 | 1993-12-14 | Tetrad Corporation | Medical ultrasonic imaging system with dynamic focusing |
EP0619104B1 (en) | 1992-09-16 | 2002-03-13 | Hitachi, Ltd. | Ultrasonic irradiation apparatus |
US5624851A (en) * | 1993-03-12 | 1997-04-29 | Semiconductor Energy Laboratory Co., Ltd. | Process of fabricating a semiconductor device in which one portion of an amorphous silicon film is thermally crystallized and another portion is laser crystallized |
US5793701A (en) * | 1995-04-07 | 1998-08-11 | Acuson Corporation | Method and apparatus for coherent image formation |
US5678553A (en) | 1994-11-01 | 1997-10-21 | Schering Aktiengesellschaft | Ultrasonic processes and circuits for carrying out those processes |
US6333021B1 (en) | 1994-11-22 | 2001-12-25 | Bracco Research S.A. | Microcapsules, method of making and their use |
IL116328A (en) * | 1994-12-16 | 1999-09-22 | Bracco Research Sa | Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging |
US5608690A (en) | 1995-03-02 | 1997-03-04 | Acuson Corporation | Transmit beamformer with frequency dependent focus |
US5833613A (en) * | 1996-09-27 | 1998-11-10 | Advanced Technology Laboratories, Inc. | Ultrasonic diagnostic imaging with contrast agents |
US5706819A (en) * | 1995-10-10 | 1998-01-13 | Advanced Technology Laboratories, Inc. | Ultrasonic diagnostic imaging with harmonic contrast agents |
JPH09222180A (en) * | 1996-02-15 | 1997-08-26 | Nabco Ltd | Three-positional solenoid valve |
AP890A (en) | 1996-02-19 | 2000-11-13 | Nycomed Imaging As | "Gas-containing contrast agents of use in diagnostic imaging. |
JPH1057374A (en) | 1996-06-11 | 1998-03-03 | Olympus Optical Co Ltd | Ultrasonograph |
US5632277A (en) * | 1996-06-28 | 1997-05-27 | Siemens Medical Systems, Inc. | Ultrasound imaging system employing phase inversion subtraction to enhance the image |
US5908389A (en) * | 1996-09-27 | 1999-06-01 | Atl Ultrasound, Inc. | Ultrasonic diagnostic imaging of harmonic frequencies with speckle reduction processing |
US5879303A (en) | 1996-09-27 | 1999-03-09 | Atl Ultrasound | Ultrasonic diagnostic imaging of response frequency differing from transmit frequency |
US6283919B1 (en) * | 1996-11-26 | 2001-09-04 | Atl Ultrasound | Ultrasonic diagnostic imaging with blended tissue harmonic signals |
US5919137A (en) * | 1996-12-04 | 1999-07-06 | Acuson Corporation | Ultrasonic diagnostic imaging system with programmable acoustic signal processor |
US5891038A (en) * | 1996-12-30 | 1999-04-06 | General Electric Company | Method, apparatus and applications for combining transmit wave functions to obtain synthetic waveform in ultrasonic imaging system |
US5833615A (en) | 1997-05-09 | 1998-11-10 | Thomas Jefferson University | Excitation enhanced ultrasound system |
US6064827A (en) * | 1997-05-16 | 2000-05-16 | Canon Kabushiki Kaisha | Image stabilizer |
US6050942A (en) * | 1997-07-11 | 2000-04-18 | Atl Ultrasound | Digital scanline signal processor for an ultrasonic diagnostic imaging system |
US6193659B1 (en) * | 1997-07-15 | 2001-02-27 | Acuson Corporation | Medical ultrasonic diagnostic imaging method and apparatus |
US6537222B1 (en) * | 1997-08-26 | 2003-03-25 | Koninklijke Philips Electronics N.V. | Methods for the detection of contrast agents in ultrasonic imaging |
US6095980A (en) | 1997-10-02 | 2000-08-01 | Sunnybrook Health Science Centre | Pulse inversion doppler ultrasonic diagnostic imaging |
US6155981A (en) * | 1997-11-26 | 2000-12-05 | Siemens Medical Systems, Inc. | Diagnostic ultrasonic imaging system and method for discriminating non-linearities |
US6193663B1 (en) | 1997-12-18 | 2001-02-27 | Acuson Corporation | Diagnostic ultrasound imaging method and system with improved frame rate |
AU3103099A (en) * | 1998-03-20 | 1999-10-11 | Thomas Jefferson University | Microbubble-based ultrasonic contrast agents for pressure measurements |
US6210332B1 (en) * | 1998-03-31 | 2001-04-03 | General Electric Company | Method and apparatus for flow imaging using coded excitation |
US6074348A (en) * | 1998-03-31 | 2000-06-13 | General Electric Company | Method and apparatus for enhanced flow imaging in B-mode ultrasound |
US6186949B1 (en) * | 1998-03-31 | 2001-02-13 | General Electric Company | Method and apparatus for three-dimensional flow imaging using coded excitation |
US6108572A (en) * | 1998-03-31 | 2000-08-22 | General Electric Company | Method and apparatus for harmonic imaging using multiple focal zones |
US5980459A (en) * | 1998-03-31 | 1999-11-09 | General Electric Company | Ultrasound imaging using coded excitation on transmit and selective filtering of fundamental and (sub)harmonic signals on receive |
US5902243A (en) * | 1998-04-15 | 1999-05-11 | Acuson Corporation | Ultrasonic imaging method with multiple pulse cancellation |
US6511426B1 (en) * | 1998-06-02 | 2003-01-28 | Acuson Corporation | Medical diagnostic ultrasound system and method for versatile processing |
JP4071864B2 (en) | 1998-06-19 | 2008-04-02 | ジーイー横河メディカルシステム株式会社 | Ultrasonic wave transmitter and ultrasonic imaging device |
US6605043B1 (en) * | 1998-11-19 | 2003-08-12 | Acuson Corp. | Diagnostic medical ultrasound systems and transducers utilizing micro-mechanical components |
US6066099A (en) | 1998-11-23 | 2000-05-23 | General Electric Company | Method and apparatus for high-frame-rate high-resolution ultrasonic image data acquisition |
US6645147B1 (en) * | 1998-11-25 | 2003-11-11 | Acuson Corporation | Diagnostic medical ultrasound image and system for contrast agent imaging |
US6228031B1 (en) * | 1999-02-17 | 2001-05-08 | Atl Ultrasound | High frame rate ultrasonic diagnostic imaging systems with motion artifact reduction |
US6193662B1 (en) | 1999-02-17 | 2001-02-27 | Atl Ultrasound | High frame rate pulse inversion harmonic ultrasonic diagnostic imaging system |
US6312386B1 (en) | 1999-02-19 | 2001-11-06 | Acuson Corporation | Medical ultrasound imaging system with composite delay profile |
US6120448A (en) | 1999-02-22 | 2000-09-19 | Acuson Corporation | Diagnostic medical ultrasonic imaging method and system for selectively processing harmonic and fundamental image information |
US6094827A (en) * | 1999-02-23 | 2000-08-01 | Black & Decker, Inc. | Viewing window lockout mechanism for power tool |
US6179781B1 (en) * | 1999-03-31 | 2001-01-30 | Acuson Corporation | Medical diagnostic ultrasound method and apparatus for improving doppler processing |
US6358210B2 (en) | 1999-03-31 | 2002-03-19 | Acuson Corporation | Medical diagnostic ultrasonic imaging transmit/receive method and apparatus |
US6117082A (en) * | 1999-03-31 | 2000-09-12 | Acuson Corporation | Medical diagnostic ultrasound imaging system and method with fractional harmonic seed signal |
US6241674B1 (en) * | 1999-03-31 | 2001-06-05 | Acuson Corporation | Medical ultrasound diagnostic imaging method and system with nonlinear phase modulation pulse compression |
US6210334B1 (en) * | 1999-03-31 | 2001-04-03 | Acuson Corporation | Medical diagnostic ultrasound method and apparatus for harmonic detection using doppler processing |
US6171246B1 (en) * | 1999-04-29 | 2001-01-09 | Michalakis Averkiou | Realtime ultrasonic imaging of perfusion using ultrasonic contrast agents |
US6139501A (en) * | 1999-06-08 | 2000-10-31 | Atl Ultrasound, Inc. | Coincident tissue and motion ultrasonic diagnostic imaging |
US6190322B1 (en) * | 1999-06-29 | 2001-02-20 | Agilent Technologies, Inc. | Ultrasonic imaging system and method using linear cancellation |
US6287258B1 (en) | 1999-10-06 | 2001-09-11 | Acuson Corporation | Method and apparatus for medical ultrasound flash suppression |
US6186950B1 (en) * | 1999-11-04 | 2001-02-13 | Atl Ultrasound | Ultrasonic pulse inversion harmonic separation with reduced motional effects |
IT1318444B1 (en) | 2000-04-03 | 2003-08-25 | Dideco Spa | INTRAOPERATIVE SELF-TRANSFUSION DEVICE. |
US6497665B1 (en) * | 2000-07-14 | 2002-12-24 | Koninklijke Philips Electronics N.V. | System and method for non-linear detection of ultrasonic contrast agents at a fundamental frequency |
US6319203B1 (en) | 2000-07-28 | 2001-11-20 | Atl Ultrasound | Ultrasonic nonlinear imaging at fundamental frequencies |
WO2002017296A1 (en) | 2000-08-24 | 2002-02-28 | Koninklijke Philips Electronics N.V. | Ultrasonic diagnostic imaging system transducer array with multiline patches |
US6602195B1 (en) * | 2000-08-30 | 2003-08-05 | Acuson Corporation | Medical ultrasonic imaging pulse transmission method |
ITSV20000036A1 (en) * | 2000-09-07 | 2002-03-07 | Esaote Spa | IMAGE DETECTION SYSTEM AND METHOD |
US6454714B1 (en) | 2000-10-20 | 2002-09-24 | Koninklijke Philips Electronics N.V. | Ultrasonic harmonic flash suppression |
US6436041B1 (en) * | 2000-12-22 | 2002-08-20 | Acuson Corporation | Medical ultrasonic imaging method with improved ultrasonic contrast agent specificity |
JP2002209898A (en) * | 2001-01-22 | 2002-07-30 | Toshiba Corp | Ultrasonic diagnostic device |
US7198601B2 (en) * | 2001-02-01 | 2007-04-03 | Hitachi Medical Corporation | Ultrasonic contrast medium imaging apparatus and method |
JP4232134B2 (en) * | 2001-02-01 | 2009-03-04 | 株式会社日立メディコ | Ultrasound contrast drawing device |
JP3644895B2 (en) | 2001-02-22 | 2005-05-11 | アロカ株式会社 | Ultrasonic diagnostic equipment |
JP5247958B2 (en) | 2001-06-13 | 2013-07-24 | 株式会社東芝 | Ultrasonic diagnostic apparatus and ultrasonic echo signal processing method |
ITSV20010030A1 (en) | 2001-08-14 | 2003-02-14 | Esaote Spa | METHOD AND DEVICE FOR THE TRANSMISSION OF ULTRASONIC PULSES AND THE RECEPTION OF THE ECHO SIGNALS TO A HARMONIC OF THE TRANSMISSION FREQUENCY |
US20030069504A1 (en) * | 2001-10-05 | 2003-04-10 | Siemens Medical Solutions Usa, Inc. | Receive filtering and filters for phase or amplitude coded pulse sequences |
US6709397B2 (en) * | 2001-10-16 | 2004-03-23 | Envisioneering, L.L.C. | Scanning probe |
KR100406098B1 (en) | 2001-12-26 | 2003-11-14 | 주식회사 메디슨 | Ultrasound imaging system and method based on simultaneous multiple transmit-focusing using the weighted orthogonal chirp signals |
KR100406097B1 (en) * | 2001-12-26 | 2003-11-14 | 주식회사 메디슨 | Ultrasound imaging system and method using the weighted chirp signals |
US6666824B2 (en) | 2002-04-01 | 2003-12-23 | Koninklijke Philips Electronics N.V. | System and method of dynamic automatic sensing of available dynamic range |
US6638228B1 (en) * | 2002-04-26 | 2003-10-28 | Koninklijke Philips Electronics N.V. | Contrast-agent enhanced color-flow imaging |
US7094204B2 (en) * | 2002-08-23 | 2006-08-22 | Siemens Medical Solutions Usa, Inc. | Coded excitation imaging for use with bipolar, unipolar and other waveforms |
JP4405182B2 (en) * | 2002-10-10 | 2010-01-27 | 株式会社東芝 | Ultrasonic diagnostic equipment |
US6827685B2 (en) | 2002-12-31 | 2004-12-07 | General Electric Company | Method of ultrasonic speckle reduction using wide-band frequency compounding with tissue-generated harmonics |
US6749569B1 (en) * | 2003-01-07 | 2004-06-15 | Esaote S.P.A. | Method and apparatus for ultrasound imaging |
DK1590006T3 (en) | 2003-02-04 | 2010-12-20 | Bracco Suisse Sa | Ultrasound contrast agents and methods for producing them |
US7635332B2 (en) * | 2003-02-14 | 2009-12-22 | Siemens Medical Solutions Usa, Inc. | System and method of operating microfabricated ultrasonic transducers for harmonic imaging |
US20040230121A1 (en) | 2003-02-20 | 2004-11-18 | Rune Hansen | Ultrasonic contrast agent imaging by dualband pulse transmission |
JP4557573B2 (en) * | 2003-03-14 | 2010-10-06 | 株式会社東芝 | Ultrasonic diagnostic apparatus and method of operating ultrasonic diagnostic apparatus |
ITSV20030023A1 (en) * | 2003-05-22 | 2004-11-23 | Esaote Spa | METHOD FOR THE OPTIMIZATION OF ULTRASONIC IMPULSES IN |
US7591788B2 (en) * | 2003-08-19 | 2009-09-22 | Siemens Medical Solutions Usa, Inc. | Adaptive contrast agent medical imaging |
US7654959B2 (en) * | 2003-09-03 | 2010-02-02 | Siemens Medical Solutions Usa, Inc. | Motion artifact reduction in coherent image formation |
US20080051660A1 (en) * | 2004-01-16 | 2008-02-28 | The University Of Houston System | Methods and apparatuses for medical imaging |
WO2005070299A1 (en) * | 2004-01-16 | 2005-08-04 | The University Of Houston System | Methods and apparatus for medical imaging |
GB0401199D0 (en) | 2004-01-21 | 2004-02-25 | Stichting Tech Wetenschapp | Contrast dual frequency imaging |
EP1774361A2 (en) | 2004-06-18 | 2007-04-18 | ANGELSEN, Bjorn A. J. | Ultrasonic contrast agent detection and imaging by low frequency manipulation of high frequency scattering properties |
US7004906B1 (en) * | 2004-07-26 | 2006-02-28 | Siemens Medical Solutions Usa, Inc. | Contrast agent imaging with agent specific ultrasound detection |
GB2445322B (en) | 2004-08-13 | 2008-08-06 | Stichting Tech Wetenschapp | Intravasular ultrasound techniques |
GB0418679D0 (en) | 2004-08-21 | 2004-09-22 | Stichting Tech Wetenschapp | Techniques for improving ultrasound contrast ratio |
JP2006141994A (en) * | 2004-10-20 | 2006-06-08 | Toshiba Corp | Ultrasonic diagnostic apparatus and ultrasonic diagnostic apparatus control program |
US8403852B2 (en) * | 2004-10-20 | 2013-03-26 | Kabushiki Kaisha Toshiba | Ultrasonic diagnostic apparatus and control method thereof |
GB2434449B (en) | 2006-01-24 | 2009-09-23 | Erasmus Uni | Pulse repetition rate excitation of contrast material |
US7713209B2 (en) * | 2007-05-21 | 2010-05-11 | Siemens Medical Solutions Usa, Inc. | Targeted contrast agent imaging with medical diagnostic ultrasound |
-
2007
- 2007-08-01 EP EP07813668.6A patent/EP2076179B1/en active Active
- 2007-08-01 JP JP2009523047A patent/JP5154554B2/en not_active Expired - Fee Related
- 2007-08-01 WO PCT/US2007/074996 patent/WO2008016992A1/en active Application Filing
- 2007-08-01 US US11/832,457 patent/US7967753B2/en not_active Expired - Fee Related
- 2007-08-01 CA CA2659645A patent/CA2659645C/en active Active
Also Published As
Publication number | Publication date |
---|---|
US7967753B2 (en) | 2011-06-28 |
EP2076179A1 (en) | 2009-07-08 |
JP2009545406A (en) | 2009-12-24 |
EP2076179B1 (en) | 2018-07-04 |
WO2008016992A1 (en) | 2008-02-07 |
US20080077018A1 (en) | 2008-03-27 |
CA2659645C (en) | 2015-06-30 |
JP5154554B2 (en) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2659645C (en) | Pulse inversion sequences for nonlinear imaging | |
Frinking et al. | Ultrasound contrast imaging: current and new potential methods | |
de Jong et al. | Detection procedures of ultrasound contrast agents | |
JP4667733B2 (en) | Method and apparatus for enhancing ultrasound contrast imaging using stepped chirp waveform | |
US6969353B2 (en) | Contrast-agent enhanced color-flow imaging | |
JPH11342129A (en) | System and method for imaging ultrasonic scattered body | |
JP2002542869A (en) | Real-time ultrasound imaging of perfusion using a contrast agent | |
Shen et al. | Pulse inversion techniques in ultrasonic nonlinear imaging | |
WO2010121265A1 (en) | A method for nonlinear imaging of ultrasound contrast agents at high frequencies | |
Daeichin et al. | Subharmonic, non-linear fundamental and ultraharmonic imaging of microbubble contrast at high frequencies | |
Frijlink et al. | Intravascular ultrasound tissue harmonic imaging in vivo | |
JP2007510451A (en) | System and method for ultrasound perfusion imaging | |
JP2004536655A (en) | Frequency compound apparatus and method for performing contrast imaging | |
Shen et al. | Third harmonic transmit phasing for tissue harmonic generation | |
Kirkhorn et al. | Three-stage approach to ultrasound contrast detection | |
WO2009072022A1 (en) | Ultrasonic contrast imaging with microbubble oscillation enhancement | |
JP2010268945A (en) | Ultrasonograph | |
Novell et al. | Optimization of multi-pulse sequences for nonlinear contrast agent imaging using a cMUT array | |
Renaud et al. | In vitro comparative study of the performance of pulse sequences for ultrasound contrast imaging of the carotid artery | |
Ketterling et al. | Individual perfluorocarbon nanodrop vaporization with 18-MHz plane waves | |
Sigmundsson | Subharmonic Imaging of Polymer-Shelled Contrast Agents | |
Li | Configurable Imaging Platform for Super-Harmonic Contrast-Enhanced Ultrasound Imaging | |
Hofstad | Ultrasound contrast imaging-improved tissue suppression in amplitude modulation | |
Martin | Intravascular detection of microvessel infiltration in atherosclerotic plaques: An intraluminal extension of acoustic angiography | |
JP2002209895A (en) | Ultrasonic imaging method and its apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |